Research and analysis
COVID-19: evaluation of hepatitis C homeless interventions
An evaluation of hepatitis C test and treat interventions targeted at homeless populations during the COVID-19 pandemic, to inform future service delivery.
Hepatitis C virus (HCV) is a blood borne viral infection of the liver that disproportionately affects people who are homeless. The initiative to house homeless people (outside London) in England during the COVID-19 pandemic presented an opportunity for HCV care providers to access these vulnerable individuals for testing and treatment.
This report provides an evaluation of some of these interventions and makes recommendations for future service delivery. Thus, it is of use to wide audience including:
HCV care providers and commissioners
- organisations providing services for homeless people
- public health professionals
Published 15 January 2021